Literature DB >> 18707904

The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.

Andrew N Davies1, Andrew Dickman, Colette Reid, Anna-Marie Stevens, Giovambattista Zeppetella.   

Abstract

A task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) was convened to produce some up-to-date, evidence-based, practical, clinical guidelines on the management of cancer-related breakthrough pain in adults. On the basis of a review of the literature, the task group was unable to make recommendations about any individual interventions, but was able to make a series of 12 recommendations about certain generic strategies. However, most of the aforementioned recommendations are based on limited evidence (i.e., case series, expert opinion). The task group also proposed a definition of breakthrough pain, and some diagnostic criteria for breakthrough pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707904     DOI: 10.1016/j.ejpain.2008.06.014

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  112 in total

1.  Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice.

Authors:  Juan A Virizuela; Yolanda Escobar; Javier Cassinello; Pablo Borrega
Journal:  Clin Transl Oncol       Date:  2012-07       Impact factor: 3.405

2.  Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).

Authors:  J Porta-Sales; C Pérez; Y Escobar; V Martínez
Journal:  Clin Transl Oncol       Date:  2015-12-22       Impact factor: 3.405

3.  Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain.

Authors:  Lukas Radbruch; Luis M Torres; John E Ellershaw; Antonio Gatti; Guillermo Luis Lerzo; Julia Revnic; Donald Taylor
Journal:  Support Care Cancer       Date:  2011-03-22       Impact factor: 3.603

4.  Breakthrough pain: a qualitative study involving patients with advanced cancer.

Authors:  Katherine Webber; Andrew N Davies; Martin R Cowie
Journal:  Support Care Cancer       Date:  2010-12-22       Impact factor: 3.603

5.  [Fentanyl: fast and furious?].

Authors:  W Meissner; R Sabatowski
Journal:  Anaesthesist       Date:  2013-06       Impact factor: 1.041

6.  [Questions from a pain physician reader: Evidence, empiricism, eminence - all the same?].

Authors:  W Meißner; F Petzke; R Sabatowski
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

Review 7.  Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.

Authors:  Frank Elsner; Giovambattista Zeppetella; Josep Porta-Sales; Ignacio Tagarro
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

8.  [Experiences of cancer patients with breakthrough pain and pharmacological treatments].

Authors:  L Bertram; S Stiel; F Elsner; L Radbruch; A Davies; F Nauck; B Alt-Epping
Journal:  Schmerz       Date:  2010-12       Impact factor: 1.107

Review 9.  Breakthrough pain in elderly patients with cancer: treatment options.

Authors:  Sophie Pautex; Nicole Vogt-Ferrier; Gilbert B Zulian
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

10.  Opioid switching and variability in response in pain cancer patients.

Authors:  O Corli; A Roberto; N Corsi; F Galli; M Pizzuto
Journal:  Support Care Cancer       Date:  2018-10-24       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.